Revolutionizing Wound Care with SenLore™

Enhancing wellness and functionality for hard-to-heal wounds.

Adlore pioneers a device for treating challenging lower extremity wounds, such as diabetic foot ulcers, venous stasis leg wounds, and arterial ulcers. Their innovative technology combines controlled heat, electrical pulse stimulation, and an integrated feedback sensor for continuous monitoring.

Real-time performance data is transmitted to patients through a mobile app and to clinicians via a secure Wi-Fi connection. Adlore aims to revolutionize wound care, enhancing patient well-being and reducing healthcare costs.

Backed by Evidence Based Research.

The vasculature system in diabetic patients in a constant state of vasoconstriction, which limits healing.

Heat and ES (electric stimulation) cause endothelial cells to release Nitric Oxide into smooth muscle resulting in vasodilation to increase foot circulation and promote healing.

INTRODUCING SENLORE™

Problem Statement

The prevalence of Diabetic Foot Ulcers (DFUs) poses a significant healthcare challenge, impacting both patients' well-being and the economy. Impaired circulation and nerve damage contribute to the slow healing and high recurrence rates of DFUs, leading to substantial healthcare costs.

With millions affected by diabetes in the US alone, the economic burden exceeds billions annually, emphasizing the critical need for effective interventions. Adlore's SenLore™ device aims to offer a comprehensive solution, targeting persistent and hard-to-heal wounds, particularly DFUs.

Statistics and Cost

In the US, diabetes affects about 34.2 million people (10.5% of the population) and incurs a hefty annual cost of $327 billion, with diabetic foot ulcers contributing around $11.5 billion annually. These ulcers cause prolonged healing, reduced quality of life, and productivity loss, straining both individuals and the healthcare system.

Adlore's SenLore™ device seeks to revolutionize DFU management through advanced monitoring, aiming to improve patient outcomes and alleviate the economic and healthcare burdens associated with these ulcers, fostering a more sustainable healthcare landscape.

Solution Development

Adlore's SenLore™ device is an innovative solution targeting diabetic foot ulcers (DFUs) and related wounds. Utilizing advanced technology, including controlled heat and electrical pulse stimulation, it enhances blood circulation and accelerates the healing process.

Equipped with feedback sensors and continuous monitoring, the device encourages active patient and clinician involvement, aiming to redefine comprehensive wound care management for DFU patients.

Through evidence-based research, the device's efficacy in enhancing healing rates has been confirmed. Adlore has collaborated with many great minds in the Advanced Smart Sensor & Structures field to further progress research. Our goal is to integrate pioneering elements, led by visionary entrepreneurs dedicated to advancing diabetic foot ulcer healing.

News & Updates

  • WMU Team Develops Life-Saving Boot for Diabetics

    In Kalamazoo, Michigan, Dr. Daryl Lawson's team is creating SenLore, a specialized boot to lower amputations from diabetic foot ulcers. They aim for high healing rates, conducting trials on over 100 individuals for FDA approval and insurance coverage.

  • Researchers Develop Special Boot to Save Limbs and Lives

    At Western Michigan University, the SenLore boot uses heat and electrical stimulation to heal diabetic foot ulcers and prevent amputations. Integrated with a smartphone app, it enables remote patient monitoring, undergoing FDA trials to aid millions affected by diabetes-related complications in the US.

  • PT Program Accredited, First Cohort Set to Graduate

    Western Michigan University's Doctor of Physical Therapy program has achieved initial accreditation. Dr. Stacie Fruth has led graduates to successful employment despite pandemic challenges, focusing on research in concussions and diabetes-related complications.

Connect With Us

We look forward to hearing from you! Reach out to us to explore how we can work together to advance healthcare innovation.